{
    "SPADE_N_04433": {
        "Clinical Information": [],
        "Patent Information": [
            {
                "Patent No": "US 7951385 B2",
                "Patent Link": "http://www.lens.org/lens/patent/US_7951385_B2",
                "Patent Type": "Granted Patent",
                "Publication Date": "2011-5-31",
                "Family Info": "CN101454440A,US20090297482",
                "Patent Title": "Probiotic strain and antimicrobial peptide derived therefrom.",
                "Abstract": "The invention relates to a strain of Enterococcus mundtii having probiotic qualities. The strain of E. mundtii (ST4SA) produces an antimicrobial peptide which exhibits antimicrobial activity against a broad range of bacteria. The invention also provides an isolated nucleotide sequence which codes for the antimicrobial peptide (peptide ST4SA). Another aspect of the invention relates to a process for the production of a peptide of the invention which comprises cultivating Enterococcus mundtii strain ST4SA in a nutrient medium under micro-aerophilic conditions at a temperature of between 100 â„ƒ. and 45 â„ƒ., until a recoverable quantity of said peptide is produced, and recovering said peptide. The isolated peptide of the invention may be used as an antimicrobial agent in a liquid formulation or a gel formulation as a topical treatment and may also be used as an antimicrobial agent following encapsulation in a polymer."
            },
            {
                "Patent No": "US 2023/0416797 A1",
                "Patent Link": "http://www.lens.org/lens/patent/US_2023_0416797_A1",
                "Patent Type": "Patent Application",
                "Publication Date": "2023-12-28",
                "Family Info": "JP2023548477A,EP4243844A1,CN116685204A,WO2022104321A1",
                "Patent Title": "MODULATING ANTIMICROBIAL PEPTIDE HALF-LIFE",
                "Abstract": "Methods of modulating the half-life of an antimicrobial peptide are described. The method may include administering an antimicrobial peptide to an environment where the antimicrobial peptide remains active until a specified endpoint, and on or after the specified endpoint, digesting the antimicrobial peptide with a protease to thereby inactivate the antimicrobial peptide and modulate its half-life. Compositions and kits for modulating the half-life of an antimicrobial peptide are also described."
            }
        ],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_04433",
            "Sequence": "MSQVVGGKYYGNGVSCNKKGCSVDWGKAIGIIGNNSAANLATGGAAGWKS",
            "Sequence Length": 50,
            "Peptide Name": "Sequence 12 from Patent US 7951385",
            "Source": "ENTEROCOCCUS MUNDTII ST4S",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial"
            ],
            "Frequent Amino Acids": "GAK",
            "Absent Amino Acids": "EFHOPRU",
            "Basic Residues": 5,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 19,
            "Polar Residues": 31,
            "Positive Residues": 5,
            "Negative Residues": 1,
            "Mass": 4948.53,
            "PI": 9.45,
            "Net Charge": 4,
            "Hydrophobicity": -0.11,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_00064",
                    "Similarity": 1.0,
                    "Sequence": "KYYGNGVSCNKKGCSVDWGKAIGIIGNNSAANLATGGAAGWKS"
                },
                {
                    "SPADE_ID": "SPADE_N_04435",
                    "Similarity": 1.0,
                    "Sequence": "KYYGNGVSCNKKGCSVDWGKAIGIIGNNS"
                },
                {
                    "SPADE_ID": "SPADE_N_06069",
                    "Similarity": 0.98,
                    "Sequence": "MKKLTSKEMAQVVGGKYYGNGVSCNKKGCSVDWGKAIGIIGNNSAANLATGGAAGWKS"
                }
            ]
        }
    }
}